Children's Cancer Caring Center
» cancer drugs
Published on Friday, October 19, 2012 by mcypen
NEW YORK (Reuters Health) - Children with incurable cancer can take part in early trials of a new drug's safety, but many parents may misunderstand the goals of those studies, new research finds.
When researchers test new drugs on humans, they start with phase 1 clinical trials. Those studies aren't aimed at seeing whether a drug works; instead, researchers are l...
Published on Wednesday, August 29, 2012 by mcypen
The U.S. Food and Drug Administrationapproved Afinitor Disperz (everolimus tablets for oral suspension), a new pediatric dosage form of the anti-cancer drug Afinitor (everolimus) used to treat a rare brain tumor called subependymal giant cell astrocytoma (SEGA). Afinitor Disperz is the first approved pediatric-specific dosage form developed for the treatment of a pedi...
Published on Saturday, July 7, 2012 by mcypen
WASHINGTON - When all else failed, the promise of corporate profits for pediatric cancer drugs did what cajoling to save children could not.
Legislation by Texas Rep. Michael McCaul, soon to be signed by President Barack Obama, will offer drug companies multimillion-dollar incentives to pioneer medications for rare childhood diseases that afflict too few kids to make...
Published on Friday, March 30, 2012 by mcypen
The U.S. Food and Drug Administration has announced what it called a series of steps to ensure the continued availability of vital cancer drugs that have been in dangerously short supply.
One of the drugs, methotrexate, is used in combination with other drugs to combat -- and in many cases cure -- acute lymphoblastic leukemia (ALL), the most common type of cancer in...
Published on Monday, February 20, 2012 by mcypen
Medication used to treat the most common form of childhood leukemia is in short supply, adding to the largest nationwide shortage of critical lifesaving hospital medications in nearly a decade.
All five pharmaceutical companies that make the injection drug methotrexate, which treats acute lymphoblastic leukemia by slowing the growth of cancer cells, have either slowe...
Published on Tuesday, June 7, 2011 by mcypen
REUTERS--Cancer medicines desperately needed by sick children and adults are in short supply, undermining the ability of U.S. doctors to administer treatments, top oncologists warned.
Many drugs are scarce because there is no incentive for drugmakers to manufacture low-cost generics, which have slim profit margins for pharmaceutical companies. Doctors do not expect t...
A Message From Our CEO Donate Now
Facebook
Your generous donation can help us save the life of Demetrious and so many other children just like him. Click the link below to find out how you can receive a bracelet designed exclusively for the CCCC to show your support for the children--it's our way of saying thanks for caring.
